Amneal Pharmaceuticals (Germany) Market Value

2DT Stock  EUR 7.60  0.15  1.94%   
Amneal Pharmaceuticals' market value is the price at which a share of Amneal Pharmaceuticals trades on a public exchange. It measures the collective expectations of Amneal Pharmaceuticals investors about its performance. Amneal Pharmaceuticals is trading at 7.60 as of the 8th of March 2025. This is a 1.94 percent decrease since the beginning of the trading day. The stock's lowest day price was 7.6.
With this module, you can estimate the performance of a buy and hold strategy of Amneal Pharmaceuticals and determine expected loss or profit from investing in Amneal Pharmaceuticals over a given investment horizon. Check out Amneal Pharmaceuticals Correlation, Amneal Pharmaceuticals Volatility and Amneal Pharmaceuticals Alpha and Beta module to complement your research on Amneal Pharmaceuticals.
Symbol

Please note, there is a significant difference between Amneal Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Amneal Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Amneal Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Amneal Pharmaceuticals 'What if' Analysis

In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Amneal Pharmaceuticals' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Amneal Pharmaceuticals.
0.00
02/06/2025
No Change 0.00  0.0 
In 31 days
03/08/2025
0.00
If you would invest  0.00  in Amneal Pharmaceuticals on February 6, 2025 and sell it all today you would earn a total of 0.00 from holding Amneal Pharmaceuticals or generate 0.0% return on investment in Amneal Pharmaceuticals over 30 days. Amneal Pharmaceuticals is related to or competes with LINMON MEDIA, NTG Nordic, Prosiebensat, Tencent Music, Southern Cross, ATRESMEDIA, and Transport International. Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes... More

Amneal Pharmaceuticals Upside/Downside Indicators

Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Amneal Pharmaceuticals' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Amneal Pharmaceuticals upside and downside potential and time the market with a certain degree of confidence.

Amneal Pharmaceuticals Market Risk Indicators

Today, many novice investors tend to focus exclusively on investment returns with little concern for Amneal Pharmaceuticals' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Amneal Pharmaceuticals' standard deviation. In reality, there are many statistical measures that can use Amneal Pharmaceuticals historical prices to predict the future Amneal Pharmaceuticals' volatility.
Hype
Prediction
LowEstimatedHigh
5.487.609.72
Details
Intrinsic
Valuation
LowRealHigh
5.527.649.76
Details
Naive
Forecast
LowNextHigh
5.857.9610.08
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
7.057.698.33
Details

Amneal Pharmaceuticals Backtested Returns

Amneal Pharmaceuticals secures Sharpe Ratio (or Efficiency) of -0.0147, which signifies that the company had a -0.0147 % return per unit of risk over the last 3 months. Amneal Pharmaceuticals exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Amneal Pharmaceuticals' Mean Deviation of 1.57, standard deviation of 2.14, and Risk Adjusted Performance of (0.01) to double-check the risk estimate we provide. The firm shows a Beta (market volatility) of 0.73, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, Amneal Pharmaceuticals' returns are expected to increase less than the market. However, during the bear market, the loss of holding Amneal Pharmaceuticals is expected to be smaller as well. At this point, Amneal Pharmaceuticals has a negative expected return of -0.0311%. Please make sure to confirm Amneal Pharmaceuticals' standard deviation, total risk alpha, maximum drawdown, as well as the relationship between the jensen alpha and treynor ratio , to decide if Amneal Pharmaceuticals performance from the past will be repeated at some point in the near future.

Auto-correlation

    
  -0.33  

Poor reverse predictability

Amneal Pharmaceuticals has poor reverse predictability. Overlapping area represents the amount of predictability between Amneal Pharmaceuticals time series from 6th of February 2025 to 21st of February 2025 and 21st of February 2025 to 8th of March 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Amneal Pharmaceuticals price movement. The serial correlation of -0.33 indicates that nearly 33.0% of current Amneal Pharmaceuticals price fluctuation can be explain by its past prices.
Correlation Coefficient-0.33
Spearman Rank Test-0.31
Residual Average0.0
Price Variance0.05

Amneal Pharmaceuticals lagged returns against current returns

Autocorrelation, which is Amneal Pharmaceuticals stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Amneal Pharmaceuticals' stock expected returns. We can calculate the autocorrelation of Amneal Pharmaceuticals returns to help us make a trade decision. For example, suppose you find that Amneal Pharmaceuticals has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
   Current and Lagged Values   
       Timeline  

Amneal Pharmaceuticals regressed lagged prices vs. current prices

Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Amneal Pharmaceuticals stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Amneal Pharmaceuticals stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Amneal Pharmaceuticals stock over time.
   Current vs Lagged Prices   
       Timeline  

Amneal Pharmaceuticals Lagged Returns

When evaluating Amneal Pharmaceuticals' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Amneal Pharmaceuticals stock have on its future price. Amneal Pharmaceuticals autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Amneal Pharmaceuticals autocorrelation shows the relationship between Amneal Pharmaceuticals stock current value and its past values and can show if there is a momentum factor associated with investing in Amneal Pharmaceuticals.
   Regressed Prices   
       Timeline  

Currently Active Assets on Macroaxis

Other Information on Investing in Amneal Stock

Amneal Pharmaceuticals financial ratios help investors to determine whether Amneal Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Amneal with respect to the benefits of owning Amneal Pharmaceuticals security.